Glenmark Pharmaceuticals Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Glimulin MV 2 Tablet ER is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet ER
Glimulin MV 2 Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimulin MV 2 Tablet ER is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimulin MV 2 Tablet ER.
Glimulin MV 2 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimulin MV 2 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimulin MV 2 Tablet ER is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimulin MV 2 Tablet ER is a combination medication containing Glimepiride, Metformin, and Voglibose. It's used to treat type 2 diabetes mellitus (DM). It works by improving blood glucose levels in adults when combined with a healthy diet and regular exercise.
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Glimulin MV 2 Tablet ER is contraindicated in patients with known allergies to any of its components or excipients. Additionally, it's avoided in those with moderate to severe kidney disease and inflammatory bowel diseases, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
No, combining Glimulin MV 2 Tablet ER with alcohol is not recommended. It may lower blood sugar levels and increase the risk of lactic acidosis.
Yes, Glimulin MV 2 Tablet ER can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This risk is increased if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications together.
Store Glimulin MV 2 Tablet ER in its original packaging with a tight seal. Keep it at room temperature according to the manufacturer's instructions. Dispose of unused medication safely, ensuring pets, children, and others do not access it.